• Syndax Pharmaceuticals granted inducement stock options covering 250,700 common shares to eight new employees on July 1, 2026.
• Options vest over four years, with 25% vesting after one year.
• Remaining shares vest monthly over the next 36 months, subject to continued service.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Syndax Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607011601PRIMZONEFULLFEED9755796) on July 01, 2026, and is solely responsible for the information contained therein.